An official website of the United States government
NIH Guide: Weekly Index for January 28, 2022
Weekly NIH Funding Opportunities and Notices
January 28, 2022
General Notices
-
Notice of Technical Assistance Webinar for RFA-AR-22-009, HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN)
(NOT-AR-22-016)National Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on AgingNational Institute of Dental and Craniofacial ResearchNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative Health
-
Notice of Participation of the National Institute of Dental and Craniofacial Research (NIDCR) in RFA-MD-22-004 Innovations for Healthy LivingImproving Minority Health and Eliminating Health Disparities (R43/R44- Clinical Trial Optional)
(NOT-DE-22-004)National Institute of Dental and Craniofacial Research
-
NIDDK Encourages Research on Sex/Gender Differences, Sexual and Gender Minority-Related Research and Race/Ethnic Diversity
(NOT-DK-22-003)National Institute of Diabetes and Digestive and Kidney Diseases
-
RESCINDED - Request for Information (RFI) on Advancing Research in Fundamental Neuroscience
(NOT-NS-22-068)National Institute of Neurological Disorders and Stroke
-
Request for Information (RFI) on Advancing Research in Fundamental Neuroscience
(NOT-NS-22-073)National Institute of Neurological Disorders and Stroke
-
Request for Public Comments on DRAFT Supplemental Information to the NIH Policy for Data Management and Sharing: Responsible Management and Sharing of American Indian/ Alaska Native Participant Data
(NOT-OD-22-064)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice of NIAAA's Participation in RFA-DA-22-047, "HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional)"
(NOT-AA-22-008)National Institute on Alcohol Abuse and Alcoholism
-
Notice of NIAAA's Participation in RFA-DA-22-048, "HEAL Initiative: Pilot & Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional)"
(NOT-AA-22-009)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Correction to Award Project Period Information for PAS-19-316, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
(NOT-AG-22-011)National Institute on AgingNational Institute of Neurological Disorders and Stroke
-
Notice of Correction to Award Project Period Information for PAS-19-317, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
(NOT-AG-22-012)National Institute on AgingNational Institute of Neurological Disorders and Stroke
-
NEI Notice of Participation in PAR-20-310, "Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)"
(NOT-EY-22-005)National Eye Institute
-
NEI Notice of Participation in PAR-21-081, "Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)"
(NOT-EY-22-006)National Eye Institute
-
NEI Notice of Participation in PAR-22-072, "Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)"
(NOT-EY-22-007)National Eye Institute
-
Notice of Change to Application Types Allowed for RFA-MH-22-120, "Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional)"
(NOT-MH-22-150)National Institute of Mental Health
-
Notice to Extend the Expiration Date for PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"
(NOT-OD-22-066)National Institutes of Health
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)
(NOT-CA-22-041)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
(NOT-CA-22-042)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
(NOT-CA-22-043)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)
(NOT-NS-22-070)National Institute of Neurological Disorders and Stroke
Notices of Special Interest
-
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
(NOT-CA-22-037)National Cancer InstituteNational Institute on AgingNational Institute on Drug AbuseNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Nursing ResearchOffice of Behavioral and Social Sciences Research
-
Notice of Special Interest (NOSI): Discovery of the Genetic Basis of Conditions Associated with Down Syndrome for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (X01)
(NOT-OD-22-058)Office of the Director, NIHNational Institute on Deafness and Other Communication DisordersEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Neurological Disorders and Stroke
-
Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
(NOT-OD-22-069)Office of the Director, NIHNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute on Minority Health and Health DisparitiesNational Center for Advancing Translational Sciences
Funding Opportunities
-
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
(PAR-22-078)National Institutes of HealthNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthApplication Receipt Date(s): June 24, 2022
-
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
(RFA-HL-23-010)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
(RFA-HL-23-011)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
(RFA-HL-23-012)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
(RFA-HL-23-013)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
(RFA-HL-23-014)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): November 21, 2024
-
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
(RFA-MH-22-115)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): May 7, 2023
-
NIMH Instrumentation Program (S10 Clinical Trial Not Allowed)
(RFA-MH-22-155)National Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)
(RFA-NR-22-001)National Institute of Nursing ResearchNational Institute on Drug AbuseNational Institute of Mental HealthOffice of Behavioral and Social Sciences ResearchOffice of Disease PreventionNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): April 7, 2022
-
Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required)
(RFA-NR-22-002)National Institute of Nursing ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentOffice of Research on Women's HealthNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): April 7, 2022
-
Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional)
(RFA-NR-22-003)National Institute of Nursing ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentOffice of Research on Women's HealthApplication Receipt Date(s): April 7, 2022
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: January 16, 2025
For technical issues E-mail OER Webmaster